Genmab A/S

NASDAQ: GMAB · Real-Time Price · USD
23.82
0.40 (1.71%)
At close: Aug 19, 2025, 2:05 PM

Genmab A/S Revenue

Genmab A/S reported an annual revenue of $21.53B, reflecting a 30.67% growth. For the quarter ending March 31, 2025, Genmab A/S generated $4.93B in revenue.
Revenue (ttm)
21.53B
Revenue Growth
30.67%
Price / Sales Ratio
4.51
Revenue / Employee
8.16M
Employees
2,638
Market Cap
15.03B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 21.53B +30.67%
Dec 31, 2023 16.47B +12.87%
Dec 31, 2022 14.6B +72.07%
Dec 31, 2021 8.48B -16.11%
Dec 31, 2020 10.11B +88.43%
Dec 31, 2019 5.37B +77.38%
Dec 31, 2018 3.03B +27.89%
Dec 31, 2017 2.37B +30.25%
Dec 31, 2016 1.82B +60.29%
Dec 31, 2015 1.13B +33.24%
Dec 31, 2014 850.38M +28.15%
Dec 31, 2013 663.57M +36.92%
Dec 31, 2012 484.64M +38.10%
Dec 31, 2011 350.94M -39.71%
Dec 31, 2010 582.08M -0.68%
Dec 31, 2009 586.08M -21.34%
Dec 31, 2008 745.11M +40.71%
Dec 31, 2007 529.54M +290.67%
Dec 31, 2006 135.55M +37.60%
Dec 31, 2005 98.5M +2301.98%
Dec 31, 2004 4.1M -94.00%
Dec 31, 2003 68.33M +Infinity%
Dec 31, 2002 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.